Get started
Author

Vijaya Kumar Baksam

Observed name: Vijayakumar Baksam
ORCID: 0000-0001-8906-0752
Observed ORCID: 0000-0001-8906-0752
OpenAlex ID: A5010754836
A Critical N-Nitrosamine Impurity of Anticoagulant Drug, Rivaroxaban: Synthesis, Characterization, Development of LC–MS/MS Method for Nanogram Level Quantification
2022 · Vijaya Kumar Baksam, Nimmakayala Saritha, et al. · Chromatographia · 16
Identification and characterization of Prothionamide degradation impurities by mass spectrometry, NMR spectroscopy, and ultra high performance liquid chromatography method development
2021 · Vijaya Kumar Baksam, Nimmakayala Saritha, et al. · Journal of Separation Science · 13
Development of an effective novel validated stability‐indicating HPLC method for the resolution of brivaracetam stereoisomeric impurities
2020 · Vijayakumar Baksam, Saritha N, et al. · Chirality · 13
Separation and Characterization of the Related Substances of Bedaquiline Fumarate Using HPLC and Spectral Methods
2021 · Vijaya Kumar Baksam, Saritha Nimmakayala, et al. · Journal of Chromatographic Science · 4
Isolation and characterization of thermal degradation impurity in brimonidine tartrate by HPLC, LC–MS/MS, and 2DNMR
2021 · Vijayakumar Baksam, Saritha Nimmakayala, et al. · Journal of Pharmaceutical and Biomedical Analysis · 3
Development of HPLC method for isomeric impurities of key starting material of novel oral anticoagulant drug; Edoxaban Tosylate Monohydrate
2024 · Vijaya Kumar Baksam, Saritha Nimmakayala · Applied Chemical Engineering · 1
Development of a Stability-Indicating RP-LC Method for the Separation of a Critical Pair of Impurities and their Degradants in Zafirlukast
2012 · Thilak Kumar Thiyagarajan, Jamal Abdul Nasser Abdul Hakeem, et al. · Journal of Chromatographic Science · 1
Works count: 7
Citation count: 51
H-index: 4
I10-index: 3
Year
Topic
Type